« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 2 , Pages 409-413, 1 June 2010
Volume 77, Issue 2 , Pages 409-413, 1 June 2010
Phase I Study of Daily Irinotecan as a Radiation Sensitizer for Locally Advanced Pancreatic Cancer
To access this article, please choose from the options below
Conflict of interest: Christian Carrie, M.D., has obtained research funding from Pfizer.
PII: S0360-3016(09)00730-5
doi:10.1016/j.ijrobp.2009.05.008
© 2010 Elsevier Inc. All rights reserved.
« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 2 , Pages 409-413, 1 June 2010
Volume 77, Issue 2 , Pages 409-413, 1 June 2010
